Home LiteratureArticle Details
PMID: 3876284 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Role of C5 and recruited neutrophils in early clearance of nontypable Haemophilus influenzae from murine lungs.

Infection and immunity ·Vol. 50 ·No. 1 ·1985-10-00 ·Pages 207-12

Toews GB, Vial WC, Hansen EJ

Abstract

We used a mouse model system to investigate the pulmonary defense mechanisms involved in clearance of nontypable Haemophilus influenzae from the lower respiratory tract. The importance of the C5 complement protein molecule in polymorphonuclear leukocyte (PMN) recruitment was studied by using congenic C5-sufficient B10.D2/nSn (C5+) and C5-deficient B10.D2/oSn (C5-) mice. The C5+ and C5- mice were inoculated with saline or nontypable H. influenzae via an endobronchial catheter. Clearance of bacteria was studied by using quantitative lung cultures. Bronchoalveolar lavage was performed at several time intervals. The number of cells in the lavage fluid were counted, and chemotactic activity was assayed in lavage fluid by the leading front technique, using human PMN in modified Boyden chambers. Pulmonary clearance of bacteria was significantly impaired in the absence of C5 (P less than 0.05). The C5+ mice recruited significantly more PMN after challenge with nontypable H. influenzae than C5- mice did (P less than 0.05), but significant PMN recruitment occurred in C5- mice. Similarly, although chemotactic activity was present in both C5+ and C5- mice, significantly more intraalveolar chemotactic activity was noted in C5+ mice than in C5- mice (P less than 0.05). The C5 molecule yields important chemotaxins during this early time period, but other chemotaxins are also present within the alveoli, demonstrating the redundancy of the inflammatory response after pulmonary challenge with nontypable H. influenzae. Nitrogen mustard-induced neutropenic animals were studied to evaluate the functional importance of PMN in pulmonary clearance of nontypable H. influenzae. Pulmonary clearance of nontypable H. influenzae was significantly impaired in neutropenic animals (P less than 0.05). Our results indicate that the prompt appearance of PMN in lungs is crucial for early clearance of nontypable H. influenzae.

MeSH Terms
Animals Chemotaxis, Leukocyte Complement C5/immunology Haemophilus influenzae/immunology Immunity, Cellular/drug effects Leukocyte Count Lung/immunology,microbiology Male Mechlorethamine/pharmacology Mice Neutrophils/drug effects,immunology Time Factors
Chemicals
Complement C5 Mechlorethamine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Toews G B
Vial W C
Hansen E J
References (29)
29 references, click to expand
  1. Deficiency of the fifth component of complement in mice with an inherited complement defect.
    J Exp Med. 1967 Jan 1;125(1):1-16 PMID: 4959665
  2. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.
    Scand J Clin Lab Invest Suppl. 1968;97:77-89 PMID: 4179068
  3. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils.
    J Immunol. 1970 Mar;104(3):535-43 PMID: 4985169
  4. Macrophage proteinase and inflammation: the production of chemotactic activity from the fifth complement by macrophage proteinase.
    J Immunol. 1972 Oct;109(4):896-8 PMID: 5074336
  5. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.
    J Exp Med. 1973 Feb 1;137(2):387-410 PMID: 4568301
  6. Acute immunologic pulmonary alveolitis.
    J Clin Invest. 1974 Aug;54(2):349-57 PMID: 4277008
  7. Determinants of lung bacterial clearance in normal mice.
    J Clin Invest. 1976 Apr;57(4):811-7 PMID: 7575
  8. Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.
    J Clin Invest. 1977 Feb;59(2):273-81 PMID: 401834
  9. Immunologic reactivity of the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages.
    Am Rev Respir Dis. 1978 Jan;117(1):15-23 PMID: 619716
  10. Acute inflammatory pulmonary reactions induced by chemotactic factors.
    Am J Pathol. 1979 Jul;96(1):71-83 PMID: 464027
  11. Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization.
    J Clin Invest. 1980 Feb;65(2):268-76 PMID: 7356678
  12. A differential effect of C5a and C5a des Arg in the induction of pulmonary inflammation.
    Am J Pathol. 1980 Jul;100(1):179-92 PMID: 7395964
  13. Enhancement of neutrophils function as a result of prior exposure to chemotactic factor.
    J Clin Invest. 1980 Aug;66(2):167-75 PMID: 6249846
  14. Early bacterial clearance from murine lungs. Species-dependent phagocyte response.
    J Clin Invest. 1980 Aug;66(2):194-9 PMID: 6995480
  15. Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization.
    J Clin Invest. 1980 Sep;66(3):473-83 PMID: 6995485
  16. Alveolar macrophage lipoxygenase products of arachidonic acid: isolation and recognition as the predominant constituents of the neutrophil chemotactic activity elaborated by alveolar macrophages.
    Cell Immunol. 1980 Sep 1;54(2):390-401 PMID: 6774816
  17. Acute maxillary sinusitis in children.
    N Engl J Med. 1981 Mar 26;304(13):749-54 PMID: 6970333
  18. The pulmonary response of C5 sufficient and deficient mice to immune complexes.
    Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):434-9 PMID: 6452843
  19. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes.
    J Clin Invest. 1982 Mar;69(3):617-31 PMID: 7037853
  20. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
    J Immunol. 1982 Apr;128(4):1772-5 PMID: 6977569
  21. Nontypeable Haemophilus influenzae in the elderly.
    Arch Intern Med. 1982 Mar;142(3):537-9 PMID: 6978116
  22. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures.
    J Immunol. 1983 Jan;130(1):370-5 PMID: 6847888
  23. Granulocyte-alveolar-macrophage interaction in the pulmonary clearance of Staphylococcus aureus.
    Am Rev Respir Dis. 1983 Mar;127(3):335-41 PMID: 6830054
  24. Pneumonia and acute febrile tracheobronchitis due to haemophilus influenzae.
    Ann Intern Med. 1983 Oct;99(4):444-50 PMID: 6605104
  25. The role of C5 in polymorphonuclear leukocyte recruitment in response to Streptococcus pneumoniae.
    Am Rev Respir Dis. 1984 Jan;129(1):82-6 PMID: 6703488
  26. Early pulmonary granulocyte recruitment in response to Streptococcus pneumoniae.
    Am Rev Respir Dis. 1984 Jan;129(1):87-91 PMID: 6703489
  27. The fifth component of complement is not required for the clearance of Staphylococcus aureus.
    Am Rev Respir Dis. 1984 Apr;129(4):597-601 PMID: 6712000
  28. Pulmonary clearance of encapsulated and unencapsulated Haemophilus influenzae strains.
    Infect Immun. 1984 Aug;45(2):437-42 PMID: 6611311
  29. Aetiology of pneumonia in children in Goroka Hospital, Papua New Guinea.
    Lancet. 1984 Sep 8;2(8402):537-41 PMID: 6147602
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1985-10-00
Pages
207-12
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC262157
Subset
IM
Grants
NIAID NIH HHS · AI 17621 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com